Terms: = Lung cancer AND ENO2, HEL-S-279, NSE AND Diagnosis
400 results:
1. Application Value of CYFRA21-1 Combined with nse, CEA, and SCC-Ag in lung cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract] [Full Text] [Related]
2. cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma.
Gan Y; Kang Y; Zhong R; You J; Chen J; Li L; Chen J; Chen L
Sci Rep; 2024 Mar; 14(1):7573. PubMed ID: 38555374
[TBL] [Abstract] [Full Text] [Related]
3. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
4. Novel electrochemical platform based on C
Junping Z; Zheng W; ZhengFang T; Yue LIJ; PengHang A; Mingli Z; Hongzhi A
Sci Rep; 2024 Mar; 14(1):6350. PubMed ID: 38491108
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
Li X; Chen K; Li J; Tang X; Ruan H; Guan M
Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
[TBL] [Abstract] [Full Text] [Related]
6. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract] [Full Text] [Related]
7. Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis.
Mohamed E; García Martínez DJ; Hosseini MS; Yoong SQ; Fletcher D; Hart S; Guinn BA
Carcinogenesis; 2024 Feb; 45(1-2):1-22. PubMed ID: 38066655
[TBL] [Abstract] [Full Text] [Related]
8. [Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer].
Peng Q; Wu N; Huang Y; Zhao SJ; Tang W; Liang M; Ran YL; Xiao T; Yang L; Liang X
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):934-941. PubMed ID: 37968078
[No Abstract] [Full Text] [Related]
9. Left lung High-Density Shadow Combined with Elevated nse Ultimately Confirmed as Pulmonary Aspergillosis.
Jiang J; Li Q; Ren HQ; Zhao Q; Yang W; Fu AS; Ge YL
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948488
[TBL] [Abstract] [Full Text] [Related]
10. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic cancer.
Qin L; Sun K; Shi L; Xu Y; Zhang R
Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
[TBL] [Abstract] [Full Text] [Related]
11. Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen.
Zhang Y; Chao F; Lv L; Li M; Shen Z
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15365-15382. PubMed ID: 37639013
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of Diagnostic Value of CTC and CTDNA in Early lung cancer.
Hongwei Yao ; Lixin Wen ; Ziyan Li ; Chunwei Xia
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):57-62. PubMed ID: 37605590
[TBL] [Abstract] [Full Text] [Related]
13. [Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
Zhang K; Liu Q; Liu B; Lin D
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):700-707. PubMed ID: 37402661
[TBL] [Abstract] [Full Text] [Related]
14. Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer.
Wang N; Yao C; Luo C; Liu S; Wu L; Hu W; Zhang Q; Rong Y; Yuan C; Wang F
Clin Chem Lab Med; 2023 Nov; 61(12):2216-2228. PubMed ID: 37387637
[TBL] [Abstract] [Full Text] [Related]
15. Peripheral Blood-Derived CircVPS35L as a Potential Diagnostic Biomarker for Non-Small Cell lung cancer.
Liang N; Zhang X; Zhang L; Jiang M; Bai H; Ding C; Cai Y; Zhou C; Han Y; Gong Z
Oncology; 2023; 101(8):527-536. PubMed ID: 37307805
[TBL] [Abstract] [Full Text] [Related]
16. Evaluating the diagnostic and prognostic value of serum TuM2-PK, nse, and ProGRP in small cell lung cancer.
Li L; Zhang Q; Wang Y; Xu C
J Clin Lab Anal; 2023 Apr; 37(7):e24865. PubMed ID: 37088873
[TBL] [Abstract] [Full Text] [Related]
17. Clinical role of serum tumor markers SCC, nse, CA 125, CA 19-9, and CYFRA 21-1 in patients with lung cancer.
Sun A
Lab Med; 2023 Nov; 54(6):638-645. PubMed ID: 37052517
[TBL] [Abstract] [Full Text] [Related]
18. Thyroid hormones as biomarkers of lung cancer: a retrospective study.
Ma Z; Song P; Ji D; Zheng M; Qiu G; Liu Z; Wang B
Ann Med; 2023 Dec; 55(1):2196088. PubMed ID: 37014291
[TBL] [Abstract] [Full Text] [Related]
19. High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage lung Adenocarcinoma.
Luo R; Zhong P; Li X; Cai J; Tao Y; Xiong B; Zheng H; Zhang Z; Tang L; Yao J; Li Y; Shi Y; Han X
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):726-738. PubMed ID: 36857775
[TBL] [Abstract] [Full Text] [Related]
20. Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral lung cancer and the Relationship with CT Signs.
Huang J; Ren K
Contrast Media Mol Imaging; 2023; 2023():1421709. PubMed ID: 36851977
[TBL] [Abstract] [Full Text] [Related]
[Next]
